uniQure (NASDAQ: QURE) CMO receives new equity grants, sells shares for tax

Rhea-AI Filing Summary

uniQure N.V.’s Chief Medical Officer Walid Abi-Saab reported new equity awards and a small automatic share sale. He was granted stock options for 67,200 shares at an exercise price of $0.00 and 41,700 restricted share units, each representing the right to receive one ordinary share.

The restricted share units vest in three equal annual installments starting one year after the grant date, subject to continued service. The stock options vest 25% on the first anniversary and 6.25% quarterly thereafter until fully vested, also contingent on continued service.

Upon vesting of restricted share units, 808 ordinary shares were sold at a weighted average price of $9.06, within a $9.00–$9.22 range, solely to cover estimated withholding taxes under automatic sale instructions, not as a discretionary trade. After these transactions, he directly owned 189,669 ordinary shares.

Insider Trade Summary

Net Seller: 808 shares ($7,320)

Net Sell 3 txns

Insider Abi-Saab Walid

Role Chief Medical Officer

Sold 808 shs ($7K)

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	67,200	$0.00	--
Grant/Award	Ordinary Shares	41,700	$0.00	--
Sale	Ordinary Shares	808	$9.06	$7K

Holdings After Transaction: Stock Option (Right to Buy) — 67,200 shares (Direct); Ordinary Shares — 190,477 shares (Direct)

Footnotes (1)

1. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Abi-Saab Walid

(Last) (First) (Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM P7 11058BP

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/04/2026		A		41,700(1)	A	$0	190,477	D
Ordinary Shares	03/04/2026		S(2)		808(2)	D	$9.06(3)	189,669	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$9.04	03/04/2026		A		67,200		(4)	03/04/2036	Ordinary Shares	67,200	$0	67,200	D

Explanation of Responses:

1. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

2. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

4. The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

	/s/ Christian Klemt, Attorney-in-Fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did uniQure (QURE) disclose about Walid Abi-Saab’s recent equity awards?

uniQure reported that Chief Medical Officer Walid Abi-Saab received stock options for 67,200 shares and 41,700 restricted share units. These awards were granted at an exercise or purchase price of $0.00 per share as part of his equity compensation package.

How do Walid Abi-Saab’s new restricted share units at uniQure (QURE) vest?

The 41,700 restricted share units vest in three equal annual installments, each representing one ordinary share. Vesting begins on the first anniversary of the grant date, and each tranche requires Abi-Saab’s continued relationship with uniQure through the relevant vesting dates.

What is the vesting schedule for Walid Abi-Saab’s new uniQure (QURE) stock options?

The 67,200 stock options vest 25% on the first anniversary of the grant date, then 6.25% quarterly until fully vested. All vesting is conditioned on Abi-Saab maintaining his relationship with uniQure throughout the applicable vesting periods.

Why did Walid Abi-Saab sell 808 uniQure (QURE) shares on March 4, 2026?

The 808 shares were sold automatically upon vesting of restricted share units solely to cover estimated withholding taxes. The sale followed preset instructions in the restricted share unit agreement and was not a discretionary trade initiated by Abi-Saab.

At what prices were Walid Abi-Saab’s 808 uniQure (QURE) shares sold?

The 808 shares were sold at a weighted average price of $9.06 per share, in multiple transactions. Individual sale prices ranged from $9.00 to $9.22, with detailed breakdowns available upon request to uniQure, shareholders, or SEC staff.

How many uniQure (QURE) ordinary shares does Walid Abi-Saab hold after these transactions?

Following the March 4, 2026 transactions, Walid Abi-Saab directly owned 189,669 ordinary shares of uniQure. This figure reflects the impact of the new restricted share unit grants and the 808-share sale for tax withholding purposes.